Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.
Armani E, Rizzi A, Iotti N, Saccani F, Di Lascia MR, Tigli L, Pappani A, Marchini G, Murgo A, Capelli AM, Delcanale M, Puccini P, Villetti G, Civelli M, Beato C, Giuliani M, Mundi C, Murarolli F, Pagano M, Raveglia LF, Remelli R, Amari G.
Armani E, et al. Among authors: remelli r.
J Med Chem. 2023 Apr 27;66(8):5622-5656. doi: 10.1021/acs.jmedchem.2c02087. Epub 2023 Apr 5.
J Med Chem. 2023.
PMID: 37017110